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Abstract
Background: Breast cancer has been increased in developing countries, but there are limited data
for breast cancer risk factors in these countries. To clarify the risk for breast cancer among the
Turkish women, an university hospital based nested case-control study was conducted.
Methods: Between January 2000 and December 2006, a survey was prospectively conducted
among women admitted to clinics of Istanbul Medical Faculty for examination and/or treatment by
using a questionnaire. Therefore, characteristics of patients diagnosed with breast cancer (n =
1492) were compared with control cases (n = 2167) admitted to hospital for non-neoplastic, non-
hormone related diseases.
Results: Breast cancer risk was found to be increased in women with age (≥ 50) [95% confidence
interval (CI) 2.42–3.18], induced abortion (95% CI 1.13–1.53), age at first birth (≥ 35) (95% CI 1.62–
5.77), body mass index (BMI ≥ 25) (95% CI 1.27–1.68), and a positive family history (95% CI 1.11–
1.92). However, decreased breast cancer risk was associated with the duration of education (≥ 13
years) (95% CI 0.62–0.81), presence of spontaneous abortion (95% CI 0.60–0.85), smoking (95%
CI 0.61–0.85), breast feeding (95% CI 0.11–0.27), nulliparity (95% CI 0.92–0.98), hormone
replacement therapy (HRT) (95% CI 0.26–0.47), and oral contraceptive use (95% CI 0.50–0.69).
On multivariable logistic regression analysis, age (≥ 50) years (OR 2.61, 95% CI 2.20–3.11), induced
abortion (OR 1.66, 95% CI 1.38–1.99), and oral contraceptive use (OR 0.60, 95% CI 0.48–0.74)
were found to be associated with breast cancer risk as statistically significant independent factors.
Conclusion: These findings suggest that age and induced abortion were found to be significantly
associated with increased breast cancer risk whereas oral contraceptive use was observed to be
associated with decreased breast cancer risk among Turkish women in Istanbul.
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Background
Breast cancer is the most common site-specific cancer, and
is the leading cause of death from cancer in women [1,2].
Breast cancer incidence and mortality may have altera-
tions in different geographical areas. Although developed
countries report higher rates of breast cancer incidence
and mortality, changes in the incidence of breast cancer
are most dramatic in low-middle income countries (LMC)
including Turkey [3]. According to World Health Organi-
zation (WHO), countries were classified into four catego-
ries regarding their resources: basic, limited, enhanced,
and maximal. Turkey is a middle income country between
limited and enhanced level regarding their sources [2,4,5].
Breast cancer incidence has increased in Turkey, and the
estimated number of breast cancer cases was 44,253 in
2007 [6,7]. The distribution of breast cancer incidence
varies significantly among different regions of Turkey due
to geographical, economic, social, and cultural factors.
The breast cancer incidence in Western Turkey (50/
100,000 in 2000) is more than two times that of Eastern
Turkey (20/100,000) due to 'Westernized' lifestyles (early
menarche, late menopause, first birth >30 years of age,
less breast-feeding, etc.), an ill-defined surrogate for
changes in patterns of childbearing, dietary habits, expo-
sures to exogenous hormones, and possibly other factors
similar to those of women in industrialized countries
[2,7-9]. Breast cancer frequency has been found to be 20%
among women <40 years old in Turkey, whereas it was
found to be around 5% in Western Europe and USA.
There is also geographical heterogeneity regarding breast
cancer survival rates in Turkey. Five year breast cancer spe-
cific survival rates are 85% and 60% in western and east-
ern Turkey, respectively [9].
Numerous epidemiological studies on risk factors of
breast cancer have produced evidence on international
variations. Many studies in the literature have reported
that breast cancer is related to the reproductive life of
women; such as early menarche, late menopause, nulli-
parity, late age at first birth, diet, physical exercise and
hormone usage [9-11]. These studies are limited among
women of developing countries to identify the risk factors
to conduct new prevention strategies. Hence, there is a
need to develop clinical practice guidelines oriented
toward countries with limited financial resources. There-
fore, we aimed to assess various breast cancer risk factors
to identify the characteristics among Turkish women in
Istanbul.
Methods
Between January 2000 and December 2006, we con-
ducted a large university hospital based-nested case con-
trol study among Turkish women with or without breast
cancer. A survey was prospectively conducted among
women in clinics of Istanbul Medical Faculty by using a
questionnaire. The Istanbul University Medical Faculty
hospital is one of the busiest hospitals located in Istanbul,
and over 80% of the outpatients reside in Istanbul which
is the biggest city in Turkey with a population of 15 mil-
lion. People who live in Istanbul have migrated from all
around the Turkey. Istanbul University Medical Faculty
Hospital accepts new outpatients with or without doctor's
referral. Therefore, one may think that the outpatient pop-
ulation does reflect a general outpatient population in any
hospital in Turkey. The control group consisted of 2167
women, between 18 to 70 years of age, without any
known chronic illnesses (e.g. hypertension, diabetes mel-
litus, coronary artery disease), any neoplastic and hor-
mone related diseases, selected from the waiting area of
different clinics by convenience sampling. Cases with
breast cancer were either selected from patients visiting
our Breast Clinic for follow-up, or from our breast cancer
database with age between 18 to 70 years (n = 1492).
Sampling was not performed for both case and control
group. An institutional ethical committee approval was
obtained before starting with the study. All interviews
were conducted at the hospital. Data were collected by a
face to face interview using a questionnaire form after hav-
ing the informed consents signed by the participants. The
questionnaire consisted of 25 questions related to general
characteristics of women (age, education, social status,
body mass index (BMI), smoking (current smokers), alco-
hol intake), menstrual and reproductive history (use of
hormone replacement therapy, age at menopause, age at
first birth, breast feeding) and family history of breast can-
cer. The data was stored by using Microsoft Access pro-
gram and the statistical analyses were performed by SPSS
15.0 program (SPSS Inc, Chicago, Illinois). The body
mass index was calculated as weight (kg)/height2 (m2).
The chi-square test was used in the statistical analyses to
evaluate the significant factors associated with breast can-
cer risk by estimating the odds ratio (OR) and 95% confi-
dence intervals (CI). Logistic regression was used to
construct a multivariable model of independent factors
associated with breast cancer risk. Forward stepwise
regression was used for factor selection and, only factors
with a frequency >10% that exhibited univariate signifi-
cance levels of less than 0.05 were examined. For each fac-
tor in the model, the likelihood of breast cancer risk was
estimated by the odds ratios and 95% CI. A p value of <
0.05 was considered significant in the statistical analyses.
Results
The distribution of patients with breast cancer (n = 1492)
and control cases (n = 2167) according to sociodemo-
graphic characteristics (age, education, body mass index
(BMI), smoking (independent from the total time), alco-
hol intake and family history of breast cancer) was shown
in Table 1. The distribution of patients with breast cancerWorld Journal of Surgical Oncology 2009, 7:37 http://www.wjso.com/content/7/1/37
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(n = 1492) and control cases (n = 2167) according to
menstrual and reproductive factors were shown in Table
2.
Patients with age (≥ 50 years) (OR 2.78, 95% CI 2.42–
3.18) or induced abortion (OR 1.31, 95% CI 1.13–1.53),
or age over 35 at first birth (OR 3.06, 95% CI 1.62–5.77),
or BMI (≥ 25 kg/m2) (OR 1.46, 95% CI 1.27–1.68), or
first-degree family history of breast cancer (OR 1.46, 95%
CI 1.11–1.92) were more likely to have increased breast
cancer risk (Table 3). Nevertheless, factors associated with
decreased breast cancer risk were as following: education
over 13 years (OR 0.71, 95% CI 0.62–0.81), spontaneous
abortion (OR 0.71, 95% CI 0.60–0.85), smoking (OR
0.72, 95% CI 0.61–0.85), breast feeding (OR 0.17, 95%
CI 0.11–0.27), nulliparity (OR 0.95, 95% CI 0.92–0.98),
hormone replacement therapy (OR 0.35, 95% CI 0.26–
0.47), and oral contraceptive use (OR 0.59, 95% CI 0.50–
0.69) (Table 3). However, total time of breast feeding has
found to no significant effect in breast cancer risk. Alcohol
intake was very limited, and less than 1% of women in
both groups received alcohol, and therefore, this factor
was not evaluated in statistical analyses.
The significant risk factors with a distribution frequency
>10% including age ≥ 50, induced abortion, BMI ≥ 25,
education  ≥ 13 years, spontaneous abortion, smoking,
breast feeding, oral contraceptive use and nulliparae were
Table 1: The distribution of women in the control group (n = 2167) and patients with breast cancer (n = 1492) according to the factors 
including age, education, body mass index (BMI), smoking and alcohol intake.
Factors women in the control group
(n = 2167)
patients with breast cancer (n = 1492)
Age (years)
≥ 35
<35
1625 (75.0%)
541 (25.0%)
1410 (94.5%)
82 (5.5%)
35–39 253 (11.7%) 120 (8.2%)
40–49 636 (29.3%) 410 (27.5%)
≥ 50 737 (34.0%) 880 (58.8%)
Education (years)
<13 1110 (51.2%) 891 (59.7%)
≥ 13 1057 (48.8%) 601 (40.3%)
Body mass index (BMI-kg/m2)
<25 971 (44.8%) 534 (35.8%)
≥ 25 1196 (55.2%) 958 (64.2%)
Smoking
Never 1517 (70.0%) 1141 (76.5%)
Ever 650 (30.0%) 351 (23.5%)
Alcohol intake
Never 2166 (99.99%) 1489 (99.98%)
Ever 1 (0.01%) 3 (0.02%)
Family history of breast cancer [first-degree relative(s)]
No 2059 (95.0%) 1384 (92.8%)
Yes 108 (5.0%) 108 (7.2%)World Journal of Surgical Oncology 2009, 7:37 http://www.wjso.com/content/7/1/37
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Table 2: The distribution of women in the control group (n = 2167) and patients with breast cancer (n = 1492) according to the 
reproductive factors.
Factors women in the control group
(n = 2167)
patients with breast cancer
(n = 1492)
Number of children
Nullipara 451 (20.8%) 241(16.2%)
≥ 1 1716 (79.2%) 1251 (83.8%)
≥ 4 353 (16.3%) 324 (21.7%)
1 312 (14.4%) 238 (12.4%)
2 678 (31.3%) 506 (33.9%)
3 373 (17.2%) 183 (15.8%)
Age at first birth (years)
<25 1697 (78.3%) 1158 (77.6%)
25–29 353 (16.3%) 231 (15.5%)
30–34 99 (4.6%) 64 (4.3%)
≥ 35 18 (0.8%) 39 (2.6%)
Breast feeding
Never 35 (1.6%) 126 (8.5%)
Ever 2132 (98.4%) 1366 (91.5%)
Spontaneous abortion
Never 1540 (71.1%) 1156 (77.5%)
Ever 627 (28.9%) 336 (22.5%)
Induced abortion
Never 1237 (57.1%) 750 (50.3%)
Ever 930 (42.9%) 742 (49.7%)
Oral contraceptive use
Never 1565 (72.2%) 1217 (81.6%)
Ever 602 (27.8%) 275 (18.4%)
Hormone replacement therapy
Never 1933 (89.2%) 1431 (95.9%)
Ever 234 (10.8%) 61 (4.1%)
Age at menopause (years)World Journal of Surgical Oncology 2009, 7:37 http://www.wjso.com/content/7/1/37
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further evaluated in the multivariable logistic regression
analyses. Among these factors, age (≥ 50) years (OR 2.61,
95% CI 2.20–3.11), induced abortion (OR 1.66, 95% CI
1.38–1.99), and oral contraceptive use (OR 0.60, 95% CI
0.48–0.74) were found to be associated with breast cancer
risk as statistically significant independent factors (Table
4).
Discussion
We are aware that this hospital based study has some
potential biases such as selection biases (non response
bias, hospital admission bias, exclusion bias), and infor-
mation bias (interview bias, recall bias, reporting bias).
One form of hospital admission bias, the problem is that
hospitalized individuals are more likely to suffer from
many illnesses or symptoms. Thus they are probably not
representative of the target population. On the other
hand, Istanbul University Istanbul Medical Faculty Hospi-
tal is one of the busiest hospitals located in Istanbul and
over 80% of the outpatients reside in the Istanbul area,
which has a population of 15 million. This hospital
accepts new outpatients with or without doctor's referral.
Therefore, one may think that the outpatient population
may potentially reflect a general outpatient population in
this hospital in Turkey, and the control group consisted of
women with non-neoplastic and non-hormone related
illnesses selected from the waiting area of different clinics.
Although the study was not population-based, patients
diagnosed and treated in a large Istanbul Medical Faculty
Hospital were included that limited any potential biases
related with the treatment. Furthermore, strength of this
study is its relatively large size, which provided reasonably
stable risk estimates.
The incidence of breast cancer increases with age, dou-
bling about every 10 years until the menopause. McPher-
son et al reported that, of every 1000 women aged 50, two
will recently have had breast cancer diagnosed and about
<50 1553 (71.7%) 971 (65.1%)
≥ 50 614 (28.3%) 521 (34.9%)
Table 2: The distribution of women in the control group (n = 2167) and patients with breast cancer (n = 1492) according to the 
reproductive factors. (Continued)
Table 3: Risk factors associated with increased or decreased risk of breast cancer.
Factors associated with increased breast cancer risk: women in the control group
(n = 2167) (%)
patients with breast cancer
(n = 1492) (%)
OR (95%CI) P value
Age (≥ 50) years 34.0 58.8 2.78 (2.42–3.18) < 0.001
Induced abortion 42.9 49.7 1.31 (1.13–1.53) < 0.001
Body mass index ≥ 25 55.2 64.2 1.46 (1.27–1.68) < 0.001
Family history of breast cancer (first degree relative) 5.0 7.2 1.46 (1.11–1.92) 0.008
Age at first birth (≥ 35 years) 0.9 2.6 3.06 (1.62–5.77) < 0.001
Factors associated with decreased breast cancer risk:
Education (≥ 13 years) 48.8 40.3 0.71 (0.62–0.81) < 0.001
Spontaneous abortion 28.9 22.5 0.71 (0.60–0.85) < 0.001
Smoking 29.9 23.5 0.72 (0.61–0.85) < 0.001
Breast feeding 98.4 91.5 0.17 (0.11–0.27) < 0.001
Oral contraceptive use 27.8 18.4 0.59 (0.50–0.69) < 0.001
Nullipara 20.8 16.2 0.95 (0.92–0.98) < 0.001
Hormone replacement therapy 10.8 4.1 0.35 (0.26–0.47) < 0.001World Journal of Surgical Oncology 2009, 7:37 http://www.wjso.com/content/7/1/37
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15 will have had a diagnosis made before the age of 50,
giving a prevalence of breast cancer of nearly 2% [12].
Vogel et al suggested that, the risk of breast cancer
increases among women older than 50 years of age espe-
cially who have benign breast disease, especially those
with atypical ductal or lobular hyperplasia [13]. This
study also showed that an age ≥ 50 year has effect on
increased breast cancer risk significantly both in univari-
ate and multivariable analyses.
Our study revealed that spontaneous abortion was associ-
ated with the decreased risk of breast cancer in univariate
analysis whereas induced abortion was associated with
increased breast cancer risk in both univariate and multi-
variable analyses. Some previous studies suggested that,
induced or spontaneous abortions were associated with
either increased or decreased risk of breast cancer, or no
associations could be found with breast cancer risk for
these factors [14-17]. Paoletti et al reported that a history of
spontaneous abortion was not associated with breast can-
cer risk, although the risk was slightly increased with
repeated miscarriages [18]. That study also showed that
spontaneous abortion was associated with decreased risk of
premenopausal breast cancer followed by an increased risk
of postmenopausal breast cancer [18]. In the EPIC study,
the relative risk of breast cancer of women who did not
report any previous spontaneous abortions, was signifi-
cantly found to be increased compared to those who
reported two or more spontaneous abortions than for those
reported one [19]. In the Iowa cohort, the age adjusted risk
among women who had experienced an induced abortion
was 1.1 compared to those who never had an induced abor-
tion [20]. Furthermore, Michels et al found a positive asso-
ciation between induced abortion and breast cancer risk in
women younger than 50, and a negative association in
older women [21]. Therefore, similar to our findings the
majority of the studies reported that induced abortion was
associated with increased breast cancer risk.
It was found that hormone replacement therapy (HRT)
and oral contraceptive use were directly related to breast
cancer risk in many epidemiologic studies [22-25]. Con-
versely, other studies reported that oral contraceptive use
did not increase breast cancer risk [26,27]. In the present
study, we found that use of oral contraceptive use was
associated with decreased breast cancer risk in both uni-
variate and multivariable analyses whereas HRT was inter-
estingly found to be associated with decreased breast
cancer risk only in univariate analysis. However, these
results were not dose and duration dependent. Therefore,
further studies are required to test the consistency of our
findings.
Tavani et al suggested [28] that older age at first birth (≥
30 years) was associated with increased breast cancer, our
results did support their data that being equal or more
than 35 years of age at first birth is associated with
increased breast cancer risk in univariate analysis. Late age
at first birth delays terminal duct proliferation of mam-
mary gland, and these women may have a higher propor-
tion of epithelial cells that are susceptible to carcinogenic
insult [29].
The most well established and documented data about
endocrinological factors that decrease breast cancer risk are
ever having breast fed and longer durations of breast feed-
ing [3,29-31]. Some studies showing a longer duration of
breast feeding decreases breast cancer risk [30,32]. Kim et
al, suggested that average duration of breast feeding for 11–
12 months reduced the breast cancer risk by 54% in Korean
women as opposed to the duration of 1 and 4 months [3].
Kuru et al [11] similarly showed that there was a significant
association in Turkish women with breast feeding and
decreased risk of breast cancer. Our data in univariate anal-
ysis also suggested that the association between decreased
risk of breast cancer and breastfeeding. However, we could
not find any relationship between the duration of breast
feeding and risk of breast cancer.
Many studies suggest that the educational level is associ-
ated with increased risk of breast cancer [33-36]. Tavani et
al [28] revealed that patients with breast cancer were sig-
nificantly more educated (>13 years) than controls [28].
This increased risk in these women may be due to the
western life style in these women associated with HRT use
or dietary changes or decreased exercise, or obesity or late
age at first birth or decreased breast-feeding. Contrary to
these findings, our study found that education (>13 years)
was associated with decreased breast cancer risk in univar-
iate analysis. These results may be due to some cultural
differences based on the fact that educated Turkish
women may be less affected by western life style com-
pared to other women in the world or due the increased
awareness for cancer screening etc.
The results of epidemiological studies of the association
between cigarette smoking and breast cancer risk have been
Table 4: Results of logistic regression model for factors 
associated with breast cancer risk.
Factors* OR (95%CI) P value
Age (≥ 50) years 2.61 (2.20–3.11) < 0.001
Induced abortion 1.66 (1.39–1.98) < 0.001
Oral contraceptive use 0.60 (0.48–0.74) < 0.001
*The significant risk factors in Table 3 with a distribution frequency 
>10% including age ≥ 50, induced abortion, BMI ≥ 25, education ≥ 13 
years, spontaneous abortion, smoking, breast feeding, oral 
contraceptive use and nullipara were further evaluated in the 
multivariable logistic regression analyses.World Journal of Surgical Oncology 2009, 7:37 http://www.wjso.com/content/7/1/37
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inconsistent [37-39]. Several recent analyses have suggested
an increased risk of breast cancer among women who
smoked cigarettes for a long period of time and/or who
started smoking before their first pregnancy [38,40-42].
Canadian National Breast Screening Study [43] reported
that there was a statistically significant association between
the duration of cigarette smoking (>40 years versus null,
OR = 1.50), or the intensity of smoking (>40 cigarettes per
day versus null, OR = 1.20), or the cumulative exposure
(>40 pack-years versus null, OR = 1.17). Cigarette smoking
appears to have antiestrogenic effects. Estrogen is well
established risk factor of breast cancer. Since smokers have
an earlier age at menopause [43], cigarette smoking might
protect against breast cancer due to its antiestrogenic
effects. In univariate analysis, our data also showed an
inverse association between cigarette smoking and breast
cancer risk. However, duration or intensity of smoking was
not investigated in the current report that might be one of
the weaknesses of this study. On the other hand, this find-
ing should not be interpreted that women should be
encouraged to smoke to decrease their breast cancer risk. It
is well known that cigarette smoking has so many potential
side effects associated with increased cancer risks for many
other types of cancer such as lung cancer, or esophageal
cancer, or laryngeal cancer etc.
One of the strongest risk factors for developing breast can-
cer is a family history of disease. In concordance with pre-
vious studies [44,45], we also found an increased breast
cancer risk associated with first-degree family history of
breast cancer (mother or sister) in univariate analysis.
Similarly, BMI equal or more than 25 was associated with
increased breast cancer risk in both previous reports [46-
51] and our current study in univariate analysis The asso-
ciation of increased breast cancer risk has been especially
well established for young premenopausal women related
to low physical activity, and anovulation in overweight
and obesity [46-51].
Conclusion
Our findings suggest that age and induced abortion were
found to be significantly associated with increased breast
cancer risk whereas oral contraceptive use was observed to
be associated with decreased breast cancer risk among
Turkish women in Istanbul in multivariable analysis. The
discrepancies between our findings and other studies in
the literature might be due to the different characteristics
of Turkish women that merit further investigation.
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